These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16678866)

  • 41. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection.
    Burger-van Paassen N; Vincent A; Puiman PJ; van der Sluis M; Bouma J; Boehm G; van Goudoever JB; van Seuningen I; Renes IB
    Biochem J; 2009 May; 420(2):211-9. PubMed ID: 19228118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Motor effects of amphetamine in rats pretreated with either dizocilpine or phencyclidine.
    Pesić V; Janać B; Milanović D; Tomić M; Veskov R; Rakić L
    Behav Brain Res; 2003 Dec; 147(1-2):211-5. PubMed ID: 14659587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of the rat CYP4A2 gene promoter by c-Jun and octamer binding protein-1.
    Fiala-Beer E; Lee AC; Murray M
    Int J Biochem Cell Biol; 2007; 39(6):1235-47. PubMed ID: 17481938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Eur J Neurosci; 2005 Aug; 22(3):715-23. PubMed ID: 16101753
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AP-1 activity rises by stimulation-dependent c-Fos expression in auditory neurons.
    Rosskothen N; Hirschmüller-Ohmes I; Illing RB
    Neuroreport; 2008 Jul; 19(11):1091-3. PubMed ID: 18596606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9.
    Ahn JS; Kim MK; Hahn JH; Park JH; Park KH; Cho BR; Park SB; Kim DJ
    Biochem Biophys Res Commun; 2008 Nov; 376(4):743-7. PubMed ID: 18809380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of 4-hydroxypanduratin A on the mitogen-activated protein kinase-dependent activation of matrix metalloproteinase-1 expression in human skin fibroblasts.
    Shim JS; Han YS; Hwang JK
    J Dermatol Sci; 2009 Feb; 53(2):129-34. PubMed ID: 19054653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of MK-801 on motor activity and c-Fos protein expression in the brain of adolescent Wistar rats.
    Pesić V; Popić J; Milanović D; Loncarević-Vasiljković N; Rakić L; Kanazir S; Ruzdijić S
    Brain Res; 2010 Mar; 1321():96-104. PubMed ID: 20114033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phorbol ester treatment of human myometrial cells suppresses expression of oxytocin receptor through a mechanism that does not involve activator protein-1.
    Ball A; Wang JW; Wong S; Zielnik B; Mitchell J; Wang N; Stemerman MB; Mitchell BF
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E922-8. PubMed ID: 16757545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blockade of AMPA-receptors attenuates 4-aminopyridine seizures, decreases the activation of inhibitory neurons but is ineffective against seizure-related astrocytic swelling.
    Weiczner R; Krisztin-Péva B; Mihály A
    Epilepsy Res; 2008 Jan; 78(1):22-32. PubMed ID: 18036781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular characterization of inflammation-induced JNK/c-Jun signaling pathway in connection with tumorigenesis.
    Kaminska B
    Methods Mol Biol; 2009; 512():249-64. PubMed ID: 19347281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bovine dialyzable leukocyte extract modulates AP-1 DNA-binding activity and nuclear transcription factor expression in MCF-7 breast cancer cells.
    Mendoza-Gamboa E; Franco-Molina MA; Zapata-Benavides P; Castillo-Tello P; Vera-García ME; Tamez-Guerra RS; Rodríguez-Padilla C
    Cytotherapy; 2008; 10(2):212-9. PubMed ID: 18368600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential regulation of prodynophin, c-fos, and serotonin transporter mRNA following withdrawal from a chronic, escalating dose regimen of D-amphetamine.
    Horner KA; Noble ES; Lauterbach EC
    Synapse; 2009 Apr; 63(4):257-68. PubMed ID: 19116947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.
    Pang M; Martinez AF; Fernandez I; Balkan W; Troen BR
    Gene; 2007 Nov; 403(1-2):151-8. PubMed ID: 17897792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.
    Hsieh YS; Chen PN; Yu CH; Liao JM; Kuo DY
    Mol Brain; 2013 Nov; 6():46. PubMed ID: 24225225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence of astrogliosis in rat hippocampus after d-amphetamine exposure.
    Frey BN; Andreazza AC; Ceresér KM; Martins MR; Petronilho FC; de Souza DF; Tramontina F; Gonçalves CA; Quevedo J; Kapczinski F
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1231-4. PubMed ID: 16631293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine on phencyclidine-induced behavior and expression of the immediate-early genes in the discrete brain regions of rats.
    Gotoh L; Kawanami N; Nakahara T; Hondo H; Motomura K; Ohta E; Kanchiku I; Kuroki T; Hirano M; Uchimura H
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):1-12. PubMed ID: 12008016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated AP-1 DNA-binding activity in rat brain during ethanol withdrawal.
    Beckmann AM; Matsumoto I; Wilce PA
    Alcohol Alcohol Suppl; 1994; 2():223-7. PubMed ID: 8974340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fos-enkephalin signaling in the rat medial vestibular nucleus facilitates vestibular compensation.
    Kitahara T; Kaneko T; Horii A; Fukushima M; Kizawa-Okumura K; Takeda N; Kubo T
    J Neurosci Res; 2006 Jun; 83(8):1573-83. PubMed ID: 16547969
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inorganic lead exposure in the rat activates striatal cFOS expression at lower blood levels and inhibits amphetamine-induced cFOS expression at higher blood levels.
    Lewis MW; Pitts DK
    J Pharmacol Exp Ther; 2004 Aug; 310(2):815-20. PubMed ID: 15111640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.